The effect of levonorgestrel intrauterine system (LNG-IUD) and etonogestrel implant (ENG implant) on hemoglobin and ferritin levels

Mehmet Alican Sapmaz; Murat Polat; Sait Erbey; Salime Nur Afşar

Makale detayları

The effect of levonorgestrel intrauterine system (LNG-IUD) and etonogestrel implant (ENG implant) on hemoglobin and ferritin levels

Yazarlar:

Mehmet Alican Sapmaz | Murat Polat | Sait Erbey | Salime Nur Afşar

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Kadın Hastalıkları ve Doğum

Dergi:

Journal of Health Sciences and Medicine Vol.8 Issue 4, pp.588-591

Belge Tipi:

Makale

Yayın Tarihi:

7/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001355822

pISSN:

2636-8579

Anahtar kelimeler:

Özet:

 Aims: The aim of the study was to compare the changes in hemoglobin Hgb and ferritin levels before and 6 months after the administration of levonorgestrel-containing intrauterine device LNG-IUD with the changes in Hgb and ferritin levels in patients with etonogestrel-containing subcutaneous implant ENG. Methods: Data for the study were collected retrospectively from eligible patients medical records on the hospital information management system. These data included Hgb gdl and ferritin mcgL values of patients with LNG-RI and ENG implants, and Hgb gdl and ferritin mcgL values measured 6 months after the implantation. The study included 80 patients with LNG-IUD and 49 patients with ENG implant. Results: When the Hgb and ferritin values of the LNG-IUD and ENG groups were compared before and after the application, it was found that both groups significantly increased Hgb and ferritin levels. When the two methods were compared with each other, it was observed that LNG-RIA was more successful in increasing Hgb and ferritin levels. Conclusion: Both LNG-IUD and ENG implant significantly increased Hgb and ferritin levels over the 6-month period; however, LNG-IUD was found to be more effective in improving these hematological parameters. Despite this, the ENG implant also demonstrated a notable increase in Hgb and ferritin levels and may be considered a valuable alternative, particularly in patients with prior intrauterine device dislocation, cervical stenosis, uterine anomalies, or myomas distorting the uterine cavity, as well as in those with contraindications to combined oral contraceptives or LNG-IUD use due to abnormal uterine bleeding or menorrhagia.

 Aims: The aim of the study was to compare the changes in hemoglobin Hgb and ferritin levels before and 6 months after the administration of levonorgestrel-containing intrauterine device LNG-IUD with the changes in Hgb and ferritin levels in patients with etonogestrel-containing subcutaneous implant ENG. Methods: Data for the study were collected retrospectively from eligible patients medical records on the hospital information management system. These data included Hgb gdl and ferritin mcgL values of patients with LNG-RI and ENG implants, and Hgb gdl and ferritin mcgL values measured 6 months after the implantation. The study included 80 patients with LNG-IUD and 49 patients with ENG implant. Results: When the Hgb and ferritin values of the LNG-IUD and ENG groups were compared before and after the application, it was found that both groups significantly increased Hgb and ferritin levels. When the two methods were compared with each other, it was observed that LNG-RIA was more successful in increasing Hgb and ferritin levels. Conclusion: Both LNG-IUD and ENG implant significantly increased Hgb and ferritin levels over the 6-month period; however, LNG-IUD was found to be more effective in improving these hematological parameters. Despite this, the ENG implant also demonstrated a notable increase in Hgb and ferritin levels and may be considered a valuable alternative, particularly in patients with prior intrauterine device dislocation, cervical stenosis, uterine anomalies, or myomas distorting the uterine cavity, as well as in those with contraindications to combined oral contraceptives or LNG-IUD use due to abnormal uterine bleeding or menorrhagia.

 Aims: The aim of the study was to compare the changes in hemoglobin Hgb and ferritin levels before and 6 months after the administration of levonorgestrel-containing intrauterine device LNG-IUD with the changes in Hgb and ferritin levels in patients with etonogestrel-containing subcutaneous implant ENG. Methods: Data for the study were collected retrospectively from eligible patients medical records on the hospital information management system. These data included Hgb gdl and ferritin mcgL values of patients with LNG-RI and ENG implants, and Hgb gdl and ferritin mcgL values measured 6 months after the implantation. The study included 80 patients with LNG-IUD and 49 patients with ENG implant. Results: When the Hgb and ferritin values of the LNG-IUD and ENG groups were compared before and after the application, it was found that both groups significantly increased Hgb and ferritin levels. When the two methods were compared with each other, it was observed that LNG-RIA was more successful in increasing Hgb and ferritin levels. Conclusion: Both LNG-IUD and ENG implant significantly increased Hgb and ferritin levels over the 6-month period; however, LNG-IUD was found to be more effective in improving these hematological parameters. Despite this, the ENG implant also demonstrated a notable increase in Hgb and ferritin levels and may be considered a valuable alternative, particularly in patients with prior intrauterine device dislocation, cervical stenosis, uterine anomalies, or myomas distorting the uterine cavity, as well as in those with contraindications to combined oral contraceptives or LNG-IUD use due to abnormal uterine bleeding or menorrhagia.

 Amaç: Çalışmanın amacı, levonorgestrel içeren rahim içi araç LNG-RİA uygulanan hastaların uygulama öncesi ve uygulamadan 6 ay sonraki hemoglobin ve ferritin düzeyi değişimlerinin, Etonogestrel içeren cilt altı implant ENG uygulanan hastalarda hemoglobin ve ferritin düzeylerinin değişimleriyle karşılaştırmaktır. Materyal  Metod: Çalışma için veriler, uygun hastaların hastane bilgi yönetim sistemi üzerindeki tıbbi kayıtlarından retrospektif olarak toplanmıştır. Bu veriler arasında LNG-RİA ve ENG implant uygulanan hastaların uygulama öncesi hemoglobin HGB gdl ve ferritin mcgL değerleriyle , uygulamadan 6 ay sonra kontrollerde bakılan hemoglobin gdl ve ferritinmcgL değerleri yer almaktadır. Çalışmaya 80 tane LNG-RİA uygulanan hastayla 49 tane ENG implant uygulanan hasta dahil edilmiştir. Bulgular: LNG-RİA ve ENG uygulanan grubun uygulama öncesi ve sonrası HGB ve Ferritin değerleri karşılaştırıldığında, her iki grubunda HGB ve ferritin düzeylerini anlamlı olarak yükselttiği bulunmuştur. İki yöntemin birbiriyle karşılaştırılmasında LNG-RİAnın HGB ve ferritin düzeylerini yükseltmede daha başarılı olduğu izlenmiştir. Tartışma: ENG implantın hemoglobin ve ferritin değerlerini anlamlı derecede yükseltmesi sonucunda, daha önce intrauterin araç dislokasyonu tecrübesi olan , servikal stenozu olan , uterin anomalileri olan , uterin kaviteyi distorsiyone eden myoma uterisi olan , kombine oral kontraseptif ve LNG -RİA nın kontraendike olduğu hasta gruplarında ENG implantının, anormal uterin kanama ve menorajiye neden olan patolojilerde , LNG RİA uygulamasına alternatif bir yöntem olabileceği sonucuna varılmıştır.

Makale detayları

The effect of levonorgestrel intrauterine system (LNG-IUD) and etonogestrel implant (ENG implant) on hemoglobin and ferritin levels

Yazarlar:

Mehmet Alican Sapmaz | Murat Polat | Sait Erbey | Salime Nur Afşar

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Kadın Hastalıkları ve Doğum

Dergi:

Journal of Health Sciences and Medicine Vol.8 Issue 4, pp.588-591

Belge Tipi:

Makale

Yayın Tarihi:

7/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001355822

pISSN:

2636-8579

Levonorgestrel

intrauterine devices

etonogestrel

anemia

iron-deficiency

ferritinLevonorgetrel

Rahim içi araçlar

Etonogestrel

Menoraji

Doğum kontrol araçları

Sayı

Makale detayları

Yazarlar: Mehmet Alican Sapmaz | Murat Polat | Sait Erbey | Salime Nur Afşar

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Kadın Hastalıkları ve Doğum

Dergi: Journal of Health Sciences and Medicine Vol.8 Issue 4, pp.588-591

Belge Tipi: Makale

Yayın Tarihi: 7/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001355822

pISSN: 2636-8579

Sayı

Yazarlar:

Mehmet Alican Sapmaz | Murat Polat | Sait Erbey | Salime Nur Afşar

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Kadın Hastalıkları ve Doğum

Dergi:

Journal of Health Sciences and Medicine Vol.8 Issue 4, pp.588-591

Belge Tipi:

Makale

Yayın Tarihi:

7/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001355822

pISSN:

2636-8579